Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine

25/06/2021
08/05/2026
EU PAS number:
EUPAS41623
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C4591021_PROTOCOL_20MAY2021____

English (844.83 KB - PDF) View document
Updated protocol

C4591021_PROTOCOL AMENDMENT 6 V8.0_22JUL2025.pdf

First published: 06/05/2026
English (1.23 MB - PDF) View document

C4591021_PROTOCOL AMENDMENT 5_V7.0_15MAY2024.pdf

First published: 18/06/2024
English (1.22 MB - PDF) View document
Study results
Study report
Abstract of study report

C4591021 Final Report Abstract.pdf

English (170.44 KB - PDF) View document
Study report

C4591021_PROGRESS REPORT_27SEP2021

English (1.82 MB - PDF) View document

C4591021 NI Study Report Abstract - interim 1.pdf

English (1.29 MB - PDF) View document

c4591021-interim2-abstract.pdf

English (1.84 MB - PDF) View document

c4591021-interim3-abstract.pdf

English (659.37 KB - PDF) View document

c4591021-interim-abstract.pdf

English (703.59 KB - PDF) View document

C4591021 Interim 5 Study Report Abstract .pdf

English (120.38 KB - PDF) View document

C4591021 Final Report.pdf

English (11.81 MB - PDF) View document
Other information
Study, other information

C4591021_PROTOCOL AMENDMENT 2_31MAR2022

English (4.11 MB - PDF) View document